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ABSTRACT
Context: Despite the increasing knowledge about the potential effect of vitamin D deficiency on ovarian reserve of 
premenopausal women, the burden of this disorder among ‘at risk’ women in sub‑Saharan Africa is notably scanty.
Aims:
• To determine the prevalence of vitamin D deficiency among premenopausal Nigerian women
• To assess the relationship between serum 25‑hydroxyvitamin D [25(OH)D] and serum anti‑mullerian hormone (AMH).
Settings and Design: A prospective cross‑sectional study of 218 premenopausal Nigerian women, attending a tertiary 
hospital in Lagos.
Materials and Methods: Serum levels of 25(OH)D and AMH were assayed using ELIZA technique, for each eligible 
participant.
Statistical Analysis Used: To determine the association between serum vitamin D and serum AMH were Kruskal‑Wallis 
test and Pearson’s correlation coefficient. Data analysis was performed on 211 participants with complete data.
Results: The mean (± SD) concentrations of serum 25(OH)D and AMH were 37.8 (± 21.4) ng/ml and 1.6 (± 0.6) ng/ml, 
respectively. The proportion of study participants with serum vitamin D deficiency, insufficiency and sufficiency were 18.5%, 
24.6%, and 56.9%, respectively. There was no statistically significant difference in the mean serum AMH among participants 
with deficient, insufficient, and sufficient vitamin D levels (1.41 ng/ml versus 1.56 ng/ml versus 1.59 ng/ml, P value = 0.539). 
Overall, there was no correlation between serum 25(OH)D, and serum AMH (r = 0.056, P > 0.05).
Conclusion: Although the proportion of women with subnormal levels of serum vitamin D was relatively high, there was no 
association between serum levels of vitamin D and AMH.
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Introduction
Vitamin D is an essential steroid hormone, synthesized 
mainly by the skin on exposure to ultraviolent B radiation. 
The 25-hydroxyvitamin D [25(OH)D] is the circulating form of 
vitamin D, and more than 80% is bound to vitamin D binding 
protein.[1] The assay of 25(OH)D reflects the total body store 
of vitamin D, and indicates an individual’s vitamin D status. In 
the human body, 25(OH)D is converted to the physiologically 
active form, 1,25-dihydroxyvitamin D, by the action of 
1-α-hydroxylase enzyme.[2]
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Vitamin D plays an important role in the maintenance of 
calcium and phosphate homeostasis. In addition to skeletal 
health, vitamin D has several other important biological 
effects and functions including normal cell division and 
differentiation. Vitamin D also contributes to the normal 
function of the immune system and nervous system, and 
normal function of other hormones such as parathyroid 
hormone and insulin.[3,4]
The biological action of vitamin D is mediated through 
vitamin D receptor (VDR), which is found in calcium regulating 
tissues such as the intestine, bone, and parathyroid glands.[5] 
Interestingly, VDR has also been identified in the female 
reproductive organs such as the uterus and the granulosa 
cells of the ovary. The identification of VDR in the female 
reproductive system suggests that vitamin D plays an 
important role in female reproduction.[5,6] In animal studies, 
VDR knockout mice showed reproductive dysfunctions 
such as uterine hypoplasia, impaired folliculogenesis, and 
hypergonadotrophic hypogonadism.[7] In human ovarian cells, 
studies have shown that vitamin D increases the production 
of ovarian hormones such as progesterone, estradiol and 
estrone.[8,9] In addition, the recognition of functional VDR 
element in the promoter region of the anti-mullerian 
hormone (AMH) gene suggests that vitamin D modulates 
AMH secretion.[10] AMH is secreted by granulosa cells of 
primary, preantral, and small antral follicles undergoing 
gonadotropin-independent development. It inhibits 
recruitment of primordial follicles into folliculogenesis.[11] 
In female reproductive physiology, AMH is a reliable marker 
of ovarian reserve.
Several studies have shown an association between serum 
vitamin D and markers of ovarian reserve. A study by 
Merhi et al., reported a positive correlation between serum 
vitamin D and AMH in women aged 40 years or older.[12] 
Furthermore, Dennis et al., showed that the seasonal changes 
in AMH level correlated with the vitamin D level in women, 
and that cholecalciferol supplementation prevented the 
seasonal AMH change.[13] A study by Jukic et al., showed an 
inverse relationship between serum vitamin D and serum 
follicular stimulating hormone (FSH) – a marker of ovarian 
reserve.[14] These studies suggest a relationship exists 
between vitamin D and ovarian reserve. In contrast, some 
studies have shown no relationship between serum vitamin 
D and AMH in premenopausal women.[15-17] Furthermore, 
vitamin D supplementation studies reported inconsistent 
effect on serum AMH level in premenopausal women.[18,19] 
Interestingly, none of these studies was conduct among 
dark-skinned women in sub-Saharan Africa at risk of vitamin 
D deficiency.
The global picture of vitamin D deficiency shows a major 
unrecognized epidemic in women of reproductive age, 
particularly in women with dark skin pigmentation.[20] 
Paradoxically, little is known of the potential effect of vitamin 
D deficiency on the ovarian reserve of dark-skinned women 
in sub-Saharan Africa. This study aims to determine the 
prevalence of vitamin D deficiency among premenopausal 
Nigerian women and to assess the relationship between 
serum 25(OH)D and AMH.
Materials and Methods
This was a prospective cross-sectional study performed at 
the gynecological outpatient clinic of the Lagos University 
Teaching Hospital (LUTH) Lagos, from September to 
December 2016.
The study participants were women aged between 18 
and 49 years, who presented at the clinic with benign 
gynecological conditions such as infertility, uterine fibroids, 
and menstrual irregularity. Excluded from the study were 
women who had undergone ovarian surgery, pelvic radiation, 
cancer chemotherapy, and women who had systemic medical 
conditions such as diabetes, hypertension, parathyroid 
and kidney diseases. Also, women on exogenous steroid, 
hormonal therapy, calcium and/or vitamin D supplementation 
were excluded.
After counselling potential participants on the study 
objectives and study procedures, consecutive eligible 
participants who signed written informed consent were 
recruited into the study. A total of 218 women was recruited 
for the study. Each participant was interviewed using a 
structure questionnaire. Information obtained during 
the interview included socio-demographic data, medical 
history, medication history including hormonal therapy, 
calcium and vitamin D supplementation, the average 
number of daytime hours spent outdoor per day, and 
dressing style. The subject’s skin complexion was recorded 
as evident from the face, neck, hands and feet. Each 
participant was also weighed and height measured using 
a weighing scale and stadiometer (SECA 220, Hamburg, 
Germany). Five milliliters of venous blood was collected 
in plain bottle from each participant. The blood sample 
was allowed to clot and serum separated within 2 hours 
of collection. Serum samples were divided and stored in 
aliquots at –20°C.
The study was commenced after obtaining ethical approval 
from the Human Research and Ethics Committee of the LUTH 
(HREC number ADM/DCST/HREC/APP/940).
Makwe and Aliyu: Vitamin D and ovarian reserve in Nigerian women
245Tropical Journal of Obstetrics and Gynaecology / Volume 36 / Issue 2 / May‑August 2019
Laboratory assay
The laboratory analysis was performed at the Central 
Research Laboratory. The samples were run in duplicate by 
a single operator. Serum vitamin D and serum AMH assays 
were performed by an automated ELISA analyser machine 
(DNM-9602 Microplate Reader) by Madell Technology 
Corporation (California, USA).
The 25-Hydroxy Vitamin D ELISA reagent kit manufactured 
by Calbiotech (California, USA) was used for serum vitamin 
D assay. The analytical sensitivity of the assay is 2.5 ng/ml 
with a range of detection of 2.5 to 150 ng/ml. The enzyme 
immunoassay AMH/MIS kit manufactured by Immunotech, 
Beckman Coulter Laboratories (Marseille, France) was used 
for the AMH assay. The intra- and inter-assay coefficients of 
variations were less than 12.3% and 14.2%, respectively. The 
analytical sensitivity of this assay is 0.14 ng/ml, with a range 
of detection of 0.14 to 21 ng/ml. Serum AMH values below 
0.14 ng/ml were treated as a zero value of analysis.
Data management
Data analysis was done using SPSS version 20 (IBM Corp., 
Armonk, NY, USA, 2011, version 20.0). Test of normality 
was performed for continuous data using one-way 
Kolmogorov-Smirov test. Categorical data were presented 
as count (and percentages) and continuous variables 
were presented as mean (standard deviation) or median 
(interquartile range), as appropriate. The Kruskal-Wallis test 
was used to compare the mean serum concentration of AMH 
between subgroups of vitamin D status. Serum vitamin D 
status	was	 classified	 as	deficient	 (<20	ng\ml),	 insufficient	
(20‑29.9	ng\ml),	and	normal	status	(≥30	ng\ml).[21] Pearson’s 
correlation coefficient was used to determine the linear 
relationship between serum 25(OH)D and AMH levels. 
Partial correlation was adjusted for age and BMI. The level 
of statistical significance was set at 0.05.
Results
Data were complete for 211 (96.8%) of the 218 women 
recruited into the study. Of the 211 participants, 101 (47.8%) 
had infertility, 49 (23.2%) had uterine fibroids, 39 (18.6%) 
had irregular menstrual cycle, and 22 (10.4%) had other 
benign gynecological conditions. Table 1 shows the baseline 
characteristics of study participants. The mean (± SD) age 
of the participants was 33.8 (± 7.0) years and about half of 
the participants were aged 30 to 39 years. The mean body 
mass index (BMI) of participants was 25.8 (± 5.2) kg/m2 and 
over half of them were either overweight or obese. All the 
participants had dark-skinned pigmentation. None of the 
participants used sunscreen agents. Most (69.2%) of them 
had uncovered dressing style. The median outdoor stay per 
day was 7 hours with a range of 1 hour to 15 hours. Most of 
the participants neither smoked cigarette nor drank alcoholic 
beverages.
Overall, the mean (± SD) serum 25(OH)D level for the 
study participants was 37.8 (± 21.4) ng/ml with a range 
of 8.0 to 105.3 ng/ml and the mean (± SD) serum AMH 
concentration was 1.6 ng/ml (± 0.6) ng/ml with a range 
of 0.58 to 3.7 ng/ml. Of the 211 participants, 39 (18.5%) 
had vitamin D deficiency and 52 (24.6%) had vitamin D 
insufficiency.
Figure 1 shows the boxplot of serum AMH levels among 
study participants with deficient, insufficient and sufficient 
vitamin D status. The mean differences in serum AMH 
levels among subgroups of participants with deficient, 
insufficient and sufficient vitamin D status (1.41 ng/ml 
versus 1.56 ng/ml versus 1.59 ng/ml) were not statistically 
Table 1: Socio‑demographic and baseline characteristics of the 
study participants (n=211)
Variables Frequency n (%) Mean (±SD)






























Body mass index (kg/m2) 25.8 (± 5.2)
<25.0 101 (47.9)
≥25.0 110 (52.1)
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significant (P-value = 0.539). Figure 2 shows the Pearson 
correlation between serum AMH levels and serum 25(OH)D 
levels. Overall, there was no correlation between serum 
AMH and serum vitamin D (r = 0.056, P value = 0.452); even 
after adjustment for known confounders such as age and 
BMI (r = 0.048, P value = 0.490).
Discussion
This study showed that the proportion of premenopausal 
Nigerian women with vitamin D deficiency was 18.5% based 
on the Endocrine Society Clinical Practice Guideline. In 
addition, about one-quarter of the women also had vitamin 
D insufficiency. The prevalence rate of vitamin D deficiency in 
this study was lower than the 42.4% reported by Nesby-O’Dell 
et al., among African-Americans in the United States.[22] 
Similarly, Durazo-Arvizu et al., reported a higher proportion 
of vitamin D deficiency in African-American women when 
compared to Nigerian women in a study conducted among 
dark-skinned women.[23] Available data suggest that vitamin 
D deficiency is common in geographical locations with 
seasonal change in weather conditions, due to inadequate 
skin exposure to ultraviolent light.[20,24-26] In addition, the poor 
absorption of ultraviolent light by melanin in dark-skinned 
individuals reduces the synthesis of vitamin D.[20,25,26] A 
meta-analysis by Martin et al., reported a high prevalence 
rate (56%) of vitamin D deficiency among immigrants from 
sub-Saharan Africa.[24]
In our study, the relatively lower prevalence rate of vitamin 
D deficiency among premenopausal Nigerian women may 
be due to the abundant sunshine in the tropics as well as 
adequate skin exposure to ultraviolent B radiation. Nigeria 
(4º N and 14º N) is located in the tropics, and most women 
recruited in our study had lifestyle that assured adequate skin 
exposure to sunlight such as “uncovered” dressing style and 
extended outdoor activities during the daytime.
Figure 2: Correlation of serum vitamin D and AMH among the study participants
Figure  1: Distribution of  serum AMH  levels  in  study participants with 
deficient, insufficient and sufficient vitamin D status
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In this study, there was no difference in the mean serum 
AMH levels among women with different levels of serum 
vitamin D based on established cut-off values. Furthermore, 
there was no correlation between serum concentrations of 
AMH and 25(OH)D. These findings are consistent with similar 
studies by several authors, which showed no relationship 
between serum 25(OH)D, and AMH levels in premenopausal 
women.[15-17,27] In contrast, this study failed to demonstrate the 
findings by some authors that showed a correlation between 
serum vitamin D and serum AMH.[12,13,19] Interestingly, the 
studies that reported a significant correlation between serum 
vitamin D and serum AMH were not conducted in sub-Saharan 
Africa. It is plausible that the serum levels of vitamin D in 
dark-skinned women resident in sub-Saharan Africa have little 
or no effect on the serum AMH.
The strength of this study lies on its prospective design and 
study participants, who were dark-skinned women ‘at risk’ of 
vitamin D deficiency. The potential limitations of this study 
include the possibility of selection bias because the study 
was hospital-based.
Conclusion
Even though vitamin D deficiency was relatively common 
among premenopausal Nigerian women, there was no 
relationship between serum vitamin D and serum AMH. Thus, 
it can be inferred that serum vitamin D status has no effect 
on the ovarian reserve of premenopausal Nigerian women.
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